A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.

Forty-eight patients with advanced breast carcinoma who had not received prior chemotherapy (minimum follow up 21 months) were randomised to receive either adriamycin 70 mg m-2 i.v. 3-weekly for 8 cycles (Regimen A) or adriamycin 35 mg m-2 i.v. 3-weekly for 16 courses (Regimen B). Objective response...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Carmo-Pereira, J., Costa, F. O., Henriques, E., Godinho, F., Cantinho-Lopes, M. G., Sales-Luis, A., Rubens, R. D.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1987
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2001830/
https://ncbi.nlm.nih.gov/pubmed/3318902
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki